COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:30, il y a 1 année 2 mois CROSSJECT fait le point sur sa collaboration avec ETON PHARMACEUTICALS, Inc. et sur le programme ZENEO® Hydrocortisone dans le domaine de l'insuffisance surrénale CROSSJECT renforce sa collaboration avec ETON PHARMACEUTICALS pour le programme ZENEO® Hydrocortisone dans l'insuffisance surrénale, avec des depôts de dossiers prévus à partir de S2 2026 Collaboration Eton Pharmaceuticals Crossject Insuffisance Surrénale ZENEO® Hydrocortisone
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:30, il y a 1 année 2 mois CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program CROSSJECT enhances collaboration with ETON PHARMACEUTICALS Inc. on ZENEO adrenal insufficiency program, introducing new hydrocortisone formulation for the hospital market Eton Pharmaceuticals Crossject Hydrocortisone Adrenal Insufficiency ZENEO
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:00, il y a 1 année 2 mois Baloise delivers an operationally successful year and increases its dividend Baloise Holding AG reports operationally successful year with improved core business, increased dividend, and strong cash remittance of CHF 565 million. Annual results show improved combined ratio and higher return on equity Dividend Increase Annual Results Cash Remittance Core Business Baloise Holding AG
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:00, il y a 1 année 2 mois Baloise affiche un exercice fructueux au niveau opérationnel et un dividende en hausse Baloise Holding AG affiche un exercice fructueux au niveau opérationnel avec une hausse du dividende. Les résultats annuels montrent une amélioration du ratio combiné et de la rentabilité des fonds propres Rentabilité Dividende Baloise Fonds Propres Exercice
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:00, il y a 1 année 2 mois Medacta Group SA: Medacta Group SA reports an excellent performance in 2024 with an adjusted EBITDA margin1 in constant currency of 28.0% Medacta Group SA reports excellent 2024 performance with 28.0% adjusted EBITDA margin. Revenue up 16.2% in constant currency. Board proposes CHF 0.69 per share distribution. Outlook targets 13-15% revenue growth & 27% EBITDA margin for 2025 Revenue Growth Adjusted EBITDA Margin Medacta Group SA 2024 Performance 2025 Outlook
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:00, il y a 1 année 2 mois Straumann Group to present its advanced digital dentistry end-to-end workflow at the International Dental Show in Cologne Straumann Group showcases innovative digital dentistry solutions at International Dental Show, introducing Straumann AXS cloud-based platform and partnerships with SprintRay, Carestream Dental. Global launch of iEXCEL implant system and Falcon dynamic navigation solution Straumann Group Digital Dentistry AXS Platform SprintRay Partnership IEXCEL Implant System
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:00, il y a 1 année 2 mois HORNBACH Group delivers successfully in FY 2024/25 – preliminary figures underscore solid performance and relevance for customers HORNBACH Group successfully delivers in FY 2024/25 with solid performance and relevance for customers shown in preliminary figures Customer Satisfaction Preliminary Results HORNBACH Group Market Share Growth FY 2024/25
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 07:00, il y a 1 année 2 mois Toosla étudie l'opportunité d'acquérir certains actifs de la société Virtuo actuellement en redressement judiciaire afin d'accélérer sa feuille de route Toosla envisage l'acquisition partielle de Virtuo pour accélérer son développement dans la location de voitures. Prochain rendez-vous : résultats de 2024 le 10 avril 2025 Acquisition Développement Résultats 2024 Toosla Virtuo
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 06:55, il y a 1 année 2 mois TAG Immobilien AG underlines strong operating business performance by exceeding FFO I and FFO II guidance for 2024, and expects further earnings growth following completion of refinancing phase TAG Immobilien AG exceeds FFO I and FFO II guidance for 2024, anticipates further earnings growth after successful refinancing phase completion Sustainability Refinancing Earnings Growth FFO TAG Immobilien AG
COMMUNIQUÉ DE PRESSE publié le 25/03/2025 à 06:30, il y a 1 année 2 mois Amrize To Deliver Next Phase of Value Creation as Standalone Company Amrize to deliver next phase of value creation as standalone company in North American market, presenting growth strategy, financial targets, and U.S. listing plans Growth Strategy Financial Targets Value Creation North American Market Amrize
Publié le 27/05/2026 à 09:30, il y a 40 minutes Caldwell Strengthens Consumer and Private Equity Capabilities with Addition of Gabino Stuyck in Madrid
Publié le 27/05/2026 à 02:10, il y a 8 heures Western Investment Company Reports First Quarter 2026 Results and Announces Executive Personnel Changes
Publié le 27/05/2026 à 01:45, il y a 8 heures 25 minutes Organto Foods Announces Record First Quarter 2026 Financial Results
Publié le 27/05/2026 à 00:25, il y a 9 heures 45 minutes Revolve Reports Q3 F2026 Results Backed by Strong Progress Across North American Portfolio
Publié le 26/05/2026 à 22:15, il y a 11 heures 55 minutes LaFleur Announces Bought Deal Equity Offerings for Gross Proceeds of C$8 Million
Publié le 27/05/2026 à 10:05, il y a 5 minutes RAVEN2 KICKS OFF GRAND FESTIVAL UPDATE WITH NEW "WARLORD" CLASS
Publié le 27/05/2026 à 10:00, il y a 10 minutes Enlit Africa 2026: Huawei Launches Intelligent Substation Solution for Sub-Saharan Africa
Publié le 27/05/2026 à 09:35, il y a 35 minutes Cato Networks Appoints Tristan Elder as Vice President of EMEA Channel to Drive Partner Growth Across Region
Publié le 27/05/2026 à 09:30, il y a 40 minutes My Academic Story with China | Helwig Schmidt-Glintzer: Possibility, creativity, and openness are the main characteristics of Chinese culture